SARS-CoV-2 belongs to the family of enveloped, single-strand RNA viruses known as
Betacoronavirus in Coronaviridae, first reported late 2019 in China. It has since been …

Vitamin D deficiency is associated with a higher risk of SARS-CoV-2 infection and poor
outcomes of the COVID-19 disease. However, a satisfactory mechanism explaining the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly become a
global health pandemic. Among the viral proteins, RNA-dependent RNA polymerase (RdRp) …

The pandemic of coronavirus disease 2019 (COVID-19) caused by the infection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a significant impact on …

The SARS CoV-2 pandemic has affected millions of people around the globe. Despite many
efforts to find some effective medicines against SARS CoV-2, no established therapeutics …

Viral DNA and RNA polymerases are two kinds of very important enzymes that synthesize
the genetic materials of the virus itself, and they have become extremely favorable targets for …

Abstract SARS-CoV-2, the causal agent of COVID-19, is primarily a pulmonary virus that can
directly or indirectly infect several organs. Despite many studies carried out during the …

RNA-dependent RNA polymerase, also known as RdRp, is a possible therapeutic target that
could be used to suppress the proliferation of RNA viruses such as SARS-CoV-2. This …

Background: As long as COVID-19 endures, viral surface proteins will keep changing and
new viral strains will emerge, rendering prior vaccines and treatments decreasingly effective …

Bats remains as reservoirs for highly contagious and pathogenic viral families including the
Coronaviridae, Filoviridae, Paramyxoviruses, and Rhabdoviridae. Spill over of viral species …